Shenzhen Accompany Technology Co., Ltd. appears in FDA records as the applicant for a Traditional 510(k), K262932, received on August 21, 2026 and decided on October 19, 2026 with decision code SESE, described as Substantially Equivalent. The device is listed as the AMIRO Spectra 10-in-1 LED Light Therapy Mask (L3), classified under 21 CFR 878.4810 with product code OHS, device class 2, and review panel General, Plastic Surgery. The filing address is in Shenzhen, China, which is a correspondence address in the record and not evidence of a corporate headquarters. [1][2][5]

The cleared device and its regulatory classification

The FDA record identifies the cleared product as the AMIRO Spectra 10-in-1 LED Light Therapy Mask (L3), a light-based over-the-counter wrinkle reduction device. The openFDA device name field reads "Light Based Over The Counter Wrinkle Reduction," with device class 2, regulation number 878.4810, and product code OHS. The advisory committee is listed as General, Plastic Surgery. The submission is a Traditional 510(k) with no third-party review indicated, and the record notes a Summary rather than a statement. [1][5][6]

Innolitics, a medical-device software consultancy that indexes FDA records, reproduces the same identifiers for K262932: applicant Shenzhen Accompany Technology Co., Ltd., product code OHS, decision date October 19, 2026, decision SESE, submission type Traditional, regulation 21 CFR 878.4810, device class 2, and review panel General, Plastic Surgery. The FDA's own 510(k) Premarket Notification database page for K262932 is the primary public record for the submission. [2][5][6]

Product description as published by the manufacturer

AMIRO’s own product page describes the Spectra 10-in-1 LED Light Therapy Mask with eight wavelengths, 10 targeted modes, 612 LEDs and a stated 10-minute care cycle. It describes a Zones Mode that customizes wavelengths and intensity across four facial areas. These are manufacturer-published specifications; they should be distinguished from the specific device and decision scope documented in the FDA record. [4]

AMIRO's site also presents the Spectra 10-in-1 LED Mask as a new arrival and flagship product, describing precision LED care customized for every facial zone and a full-coverage design targeting fine lines, dark circles, and tired eyes. These descriptions originate with the manufacturer's published documentation and should be read as marketing statements rather than independently verified performance data. [3][7]

Applicant identity and what the records do not establish

The FDA record lists the applicant as Shenzhen Accompany Technology Co., Ltd. at 25th Floor, Gaoxin Community United Headquarters Bldg., #63, Shenzhen, with postal code 518000 and country code CN, and names Chan Fu as contact. That address is a filing address; the records do not establish a corporate headquarters, ownership structure, parent company, or subsidiary relationship. AMIRO appears as the brand on the device name and on the manufacturer's website, but the records do not document a verified legal relationship between the brand and the applicant beyond the shared product name. [1][3][4]

The available collection contains one linked 510(k) record, and the decision count for that collection is one SESE clearance. The record sample likewise contains a single entry, K262932. These counts describe the filings retrieved as of November 20, 2026 and are not measures of total company sales, total portfolio, commercial availability, or safety performance. No recall records appear in the retrieved sample. [1]

Reading the filing record

For industry readers, K262932 documents a Class 2, product code OHS clearance for a consumer LED mask, decided October 19, 2026, roughly two months after the August 21, 2026 receipt date. The record confirms the regulatory pathway and classification; it does not publish clinical outcome data, patient-selection criteria, or treatment instructions, and none should be inferred from the clearance itself. [1][5][6]